(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
The Iconic, Instantly Recognizable Plastic Chair That's Known All Around The World - 2Bowen Yang is reportedly leaving 'Saturday Night Live' after this week's episode
- 3One spent $20 on candy. Another paid $700 for a custom costume. Here's how Halloween costs stacked up this year.
- 4Flu activity rises sharply across US with 7.5 million cases, CDC data shows
- 5Figure out What Experience Level Means for Medical caretaker Compensation Dealings
- $30K Disability Scam Implodes After Surf Trip in Mexico
- Palestine weekly wrap: Protests sweep West Bank after death penalty law
- Watch live as near-Earth asteroid Eros buzzes the Andromeda Galaxy on Nov. 30 (video)
- Taylor Frankie Paul's domestic violence case is fueling discussions about DARVO. Experts say terms like this shouldn't be used lightly.
- Party Urban areas of the World
- Dancing through the crackdown: The satirical song soundtracking post-Khamenei Iran
- These 2 moon rovers used cameras and lasers to hunt for simulated water ice — and one looks like WALL-E
- Two reportedly killed as Israel attacks Hezbollah targets in Lebanon
- This Week In Space podcast: Episode 189 — Privatizing Orbit
